Bradley E. Lerman
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Starbucks Faces Growing Problem Despite Returning Customers. Starbucks is dealing with a growing problem even as customers return, according to recent reports. The stock has risen 15% year‑to‑date, prompting questions about further upside. Jim Cramer noted that Starbucks can rise on its own, highlighting the company's resilience.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MiniMed completes separation from Medtronic. Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.
Transaction History
| MCK | ▼ Sell | Open Market | 301 | $269K | 8/10/2026 | View on chart |
| SBUX | ▼ Sell | Tax Withholding | 864 | $73K | 11/14/2025 | View on chart |
| SBUX | ▲ Buy | Grant | 5,420 | $0 | 11/11/2025 | View on chart |
| MCK | ▲ Buy | Grant | 301 | $0 | 7/30/2025 | View on chart |
| SBUX | ▼ Sell | Tax Withholding | 975 | $85K | 5/15/2025 | View on chart |
| SBUX | ▲ Buy | Grant | 14,235 | $0 | 11/19/2024 | View on chart |
| SBUX | ▼ Sell | Tax Withholding | 842 | $84K | 11/14/2024 | View on chart |
| SBUX | ▼ Sell | Tax Withholding | 952 | $72K | 5/15/2024 | View on chart |
| SBUX | ▲ Buy | Grant | 13,258 | $0 | 11/14/2023 | View on chart |
| SBUX | ▲ Buy | Grant | 11,253 | $0 | 5/15/2023 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 250 | $31K | 11/5/2021 | View on chart |
| MDT | ▲ Buy | Option Exercise | 49,147 | $3.8M | 9/30/2021 | View on chart |
| MDT | ▼ Sell | Open Market | 49,147 | $6.2M | 9/30/2021 | View on chart |
| MDT | ▲ Buy | Option Exercise | 50,775 | $3.8M | 8/31/2021 | View on chart |
| MDT | ▼ Sell | Open Market | 50,775 | $6.8M | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
McKesson Re-Rated on M&A Momentum Amid Strong Performance
McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.
McKesson Re-Rated on M&A Momentum Amid Strong Performance. McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.